PRN1008 (Rilzabrutinib) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK), with an IC50 of 1.3 nM.
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
PRN1008 (Rilzabrutinib) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK), with an IC50 of 1.3 nM.
[1] Smith PF, et al. 2017 Nov;83(11):2367-2376.
没有评价数据